What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Psychiatry
The scientist’s investigation covers issues in Parkinson's disease, Psychiatry, Psychosis, Internal medicine and Clozapine.
His Parkinson's disease study results in a more complete grasp of Disease.
Joseph H. Friedman combines subjects such as Clinical Global Impression, Movement disorders, Dementia and Rating scale with his study of Psychiatry.
His Psychosis research includes elements of Quetiapine, Olanzapine and Antipsychotic, Atypical antipsychotic.
His work deals with themes such as Endocrinology and Oncology, which intersect with Internal medicine.
His Clozapine research is multidisciplinary, incorporating perspectives in Pediatrics and Parkinsonism.
His most cited work include:
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. (2766 citations)
- Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease (1020 citations)
- Validity and reliability of a rating scale for the primary torsion dystonias (799 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Parkinson's disease, Psychiatry, Disease, Pediatrics and Psychosis.
Parkinson's disease is a subfield of Internal medicine that Joseph H. Friedman explores.
His Internal medicine research focuses on Placebo and how it relates to Randomized controlled trial.
Joseph H. Friedman has researched Psychiatry in several fields, including Movement disorders, Dementia, Parkinsonism and Clinical psychology.
The concepts of his Disease study are interwoven with issues in Depression and Anxiety.
His research investigates the connection between Psychosis and topics such as Clozapine that intersect with problems in Quetiapine, Atypical antipsychotic and Anesthesia.
He most often published in these fields:
- Parkinson's disease (32.39%)
- Psychiatry (29.05%)
- Disease (22.71%)
What were the highlights of his more recent work (between 2015-2021)?
- Parkinson's disease (32.39%)
- Disease (22.71%)
- Psychiatry (29.05%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Parkinson's disease, Disease, Psychiatry, Psychosis and Internal medicine.
His Parkinson's disease study combines topics from a wide range of disciplines, such as Multidisciplinary approach, Clozapine, MEDLINE, Anxiety and Drug-naïve.
The various areas that Joseph H. Friedman examines in his Disease study include Physical therapy, Clinical trial, Pediatrics and Depression.
His study looks at the relationship between Psychiatry and topics such as Dementia, which overlap with Quality of life.
His Psychosis study integrates concerns from other disciplines, such as Movement disorders and Pimavanserin.
His Internal medicine research includes themes of Gastroenterology, Placebo and Placebo-controlled study.
Between 2015 and 2021, his most popular works were:
- Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects (475 citations)
- A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease (61 citations)
- Parkinson's disease‐related fatigue: A case definition and recommendations for clinical research (57 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Psychiatry
Joseph H. Friedman mainly focuses on Disease, Parkinsonism, Parkinson's disease, Internal medicine and Psychiatry.
His research integrates issues of Etiology and Confounding in his study of Disease.
His studies deal with areas such as Retrospective cohort study, Motor asymmetry, Valbenazine, Movement disorders and Pediatrics as well as Parkinsonism.
He conducted interdisciplinary study in his works that combined Parkinson's disease and Interleukin 1 receptor antagonist.
The Internal medicine study combines topics in areas such as Gastroenterology, Placebo and Placebo-controlled study.
His Psychiatry research incorporates themes from Clinical trial, Effective treatment and MEDLINE.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
